5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow fresolimumab: new trials by email Literature Review of fresolimumab trials Research Report on fresolimumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer Fresolimumab, Stereotactic Body Radiation Therapy - Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Completed | Maximilian Diehn | 28 | 2016-08-01 | 2024-03-27 |
| A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) fresolimumab, Placebo - Primary Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Genzyme, a Sanofi Company | 36 | 2012-08-01 | 2015-08-26 |
| Safety and Imaging Study of GC1008 in Glioma 89Zr-GC1008, GC1008 - Primary Brain Tumors | Phase 2 | Completed | University Medical Center Groningen | 12 | 2011-12-01 | 2024-05-06 |
| Fresolimumab and Radiotherapy in Metastatic Breast Cancer Fresolimumab, Radiation Therapy - Metastatic Breast Cancer | Phase 2 | Completed | Weill Medical College of Cornell University | 23 | 2011-07-01 | 2019-03-05 |
| Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma GC1008 - Pleural Malignant Mesothelioma | Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 14 | 2010-04-01 | 2020-04-10 |
Brain Neoplasms (1) · Breast Neoplasms (1) · Camurati-Engelmann Syndrome (1) · Carcinoma, Non-Small-Cell Lung (1) · Mesothelioma, Malignant (1)
Abramson Cancer Center at Penn Medicine (1) · Genzyme, a Sanofi Company (1) · Maximilian Diehn (1) · University Medical Center Groningen (1) · Weill Medical College of Cornell University (1)
United States (4) · Brazil (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1)
Annemiek ME Walenkamp, MD, PhD (1) · James Stevenson, MD (1) · Maximilian Diehn (1) · Silvia Formenti, M.D. (1)